PMID- 22987071 OWN - NLM STAT- MEDLINE DCOM- 20130114 LR - 20211021 IS - 1362-4962 (Electronic) IS - 0305-1048 (Print) IS - 0305-1048 (Linking) VI - 40 IP - 19 DP - 2012 Oct TI - p53-Independent regulation of p21Waf1/Cip1 expression and senescence by PRMT6. PG - 9534-42 LID - 10.1093/nar/gks858 [doi] AB - p21 is a potent cyclin-dependent kinase inhibitor that plays a role in promoting G1 cell cycle arrest and cellular senescence. Consistent with this role, p21 is a downstream target of several tumour suppressors and oncogenes, and it is downregulated in the majority of tumours, including breast cancer. Here, we report that protein arginine methyltransferase 6 (PRMT6), a type I PRMT known to act as a transcriptional cofactor, directly represses the p21 promoter. PRMT6 knock-down (KD) results in a p21 derepression in breast cancer cells, which is p53-independent, and leads to cell cycle arrest, cellular senescence and reduced growth in soft agar assays and in severe combined immunodeficiency (SCID) mice for all the cancer lines examined. We finally show that bypassing the p21-mediated arrest rescues PRMT6 KD cells from senescence, and it restores their ability to grow on soft agar. We conclude that PRMT6 acts as an oncogene in breast cancer cells, promoting growth and preventing senescence, making it an attractive target for cancer therapy. FAU - Phalke, Sameer AU - Phalke S AD - Division of Cancer Genetics and Therapeutics, Institute of Molecular and Cell Biology, A*STAR (Agency for Science, Technology and Research), Singapore 138673. FAU - Mzoughi, Slim AU - Mzoughi S FAU - Bezzi, Marco AU - Bezzi M FAU - Jennifer, Nancy AU - Jennifer N FAU - Mok, Wei Chuen AU - Mok WC FAU - Low, Diana H P AU - Low DH FAU - Thike, Aye Aye AU - Thike AA FAU - Kuznetsov, Vladimir A AU - Kuznetsov VA FAU - Tan, Puay Hoon AU - Tan PH FAU - Voorhoeve, P Mathijs AU - Voorhoeve PM FAU - Guccione, Ernesto AU - Guccione E LA - eng PT - Journal Article DEP - 20120916 PL - England TA - Nucleic Acids Res JT - Nucleic acids research JID - 0411011 RN - 0 (Cyclin-Dependent Kinase Inhibitor p21) RN - 0 (Nuclear Proteins) RN - 0 (Repressor Proteins) RN - 0 (Tumor Suppressor Protein p53) RN - EC 2.1.1.319 (PRMT6 protein, human) RN - EC 2.1.1.319 (Protein-Arginine N-Methyltransferases) SB - IM MH - Animals MH - Breast Neoplasms/*genetics/metabolism/pathology MH - Cell Cycle Checkpoints MH - Cell Line, Tumor MH - Cell Proliferation MH - Cellular Senescence MH - Cyclin-Dependent Kinase Inhibitor p21/*genetics MH - Female MH - *Gene Expression Regulation, Neoplastic MH - Gene Knockdown Techniques MH - Humans MH - Mice MH - Mice, SCID MH - Nuclear Proteins/genetics/*metabolism MH - Phenotype MH - Promoter Regions, Genetic MH - Protein-Arginine N-Methyltransferases/genetics/*metabolism MH - Repressor Proteins/*metabolism MH - Tumor Suppressor Protein p53/metabolism PMC - PMC3479215 EDAT- 2012/09/19 06:00 MHDA- 2013/01/15 06:00 PMCR- 2012/09/16 CRDT- 2012/09/19 06:00 PHST- 2012/09/19 06:00 [entrez] PHST- 2012/09/19 06:00 [pubmed] PHST- 2013/01/15 06:00 [medline] PHST- 2012/09/16 00:00 [pmc-release] AID - gks858 [pii] AID - 10.1093/nar/gks858 [doi] PST - ppublish SO - Nucleic Acids Res. 2012 Oct;40(19):9534-42. doi: 10.1093/nar/gks858. Epub 2012 Sep 16.